(Press-News.org) Doctors may soon be able to tell just how sick a heart failure patient really is by using a routine MRI scan, thanks to new research from the University of East Anglia.
People with heart failure often need a test called right heart catheterisation, where a tube is inserted into the heart to measure oxygen levels in the blood. This helps doctors understand how severe the condition is.
But the invasive procedure is far from pleasant and carries risks, especially for older, frail or unwell patients.
In collaboration with researchers at the University of Leeds and Newcastle University, the team developed a way to estimate this crucial measurement of blood oxygen using a standard cardiac MRI.
Now, they hope their findings could potentially spare thousands from undergoing the risky tube procedure in future.
A potential game changer
Lead researcher Prof Pankaj Garg, from UEA’s Norwich Medical School and a consultant cardiologist at the Norfolk and Norwich University Hospital, said: “Heart failure affects hundreds of thousands of people in the UK and significantly weakens the heart’s ability to pump blood. Doctors often need detailed information about a patient’s circulation to decide on the best treatment.
“We wanted to develop a safe, non-invasive alternative which could allow far more patients to be properly assessed - and allow repeat monitoring without the risks of a catheter test.
“Our breakthrough could be a game changer for assessing advanced heart failure. It could allow us to measure risk more safely and more often, especially for patients who are too frail or high-risk for an invasive catheter procedure.”
How the research happened
The team developed a method that uses a routine type of MRI measurement called T2 mapping to estimate how much oxygen is left in the blood as it returns to the heart - a key marker of how well the heart is coping.
Prof Garg said: “Blood with different oxygen levels behaves slightly differently in a magnetic field. By measuring how that blood reacts, we were able to develop a formula that predicts the oxygen reading without ever inserting a tube or taking a blood sample.”
The researchers first tested the technique in 30 patients and found the MRI results closely matched the invasive catheter readings.
They then analysed 628 people with newly diagnosed heart failure, following them for around three years. Those with healthier oxygen readings on MRI were significantly less likely to die or end up in hospital due to their condition.
Crucially, this MRI-based measure stayed accurate even after accounting for age, other illnesses and overall heart function.
Faster, safer heart checks
Prof Garg said: “One of the most important markers in advanced heart failure is how much oxygen is left in blood returning to the right side of the heart. Until now, getting that number has usually meant a tube test. Our study shows it can be estimated non-invasively from a standard heart MRI.”
Senior author Dr Peter Swoboda, from the University of Leeds, added: “This means we may be able to read off a crucial haemodynamic number from an everyday scan - effectively turning a routine MRI into a much more powerful test, without putting a tube into the heart.”
Co-author Dr Gareth Matthews, from the University of East Anglia, said: “Because this can be done as part of a standard cardiac MRI, it needs no extra hardware and no contrast dye, and adds only seconds to the scan.
“It has real potential to widen access to safer heart failure assessment across the NHS,” he added.
The researchers say further studies are needed to confirm the findings in different hospitals and patient groups, and to understand how best to use the measure in day-to-day decision-making.
‘Development and validation of a non-invasive model of mixed venous oxygen saturation in heart failure’ is published in the journal JACC Advances.
END
MRI scan breakthrough could spare thousands of heart patients from risky invasive tests
2026-01-28
ELSE PRESS RELEASES FROM THIS DATE:
Kraft Center at Mass General Brigham launches 2nd Annual Kraft Prize for Excellence and Innovation in Community Health
2026-01-28
The Kraft Center for Community Health at Mass General Brigham today announced the launch of the second annual Kraft Prize for Excellence and Innovation in Community Health, a national award recognizing organizations and innovators driving measurable improvements in community health with scalable, real-world models.
The prize will award $100,000 to one recipient addressing critical health challenges in any of a number of areas — cancer, cardiometabolic disease, substance use disorder, maternal health, ...
New tool shows how to enter and change pneumocystis fungi
2026-01-28
Highlights:
Pneumocystis fungi are difficult to study and culture, making it difficult to develop new treatments.
The fungi are thought to use extracellular vesicles (EVs) to scavenge nutrients from the environment.
Researchers have harnessed EVs to deliver CRISPR-Cas9 gene-editing technology inside the fungus.
Tests on mice showed that the method worked to modify genes in the fungus associated with treatment resistance.
Washington, D.C.—Pneumocystis is an unwieldy genus of fungal pathogens that cause severe pneumonia, particularly in immunocompromised people like those with HIV/AIDs ...
Applications of artificial intelligence and smart devices in metabolic dysfunction-associated steatotic liver disease
2026-01-28
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a highly prevalent chronic liver condition globally, with its management spanning risk assessment, early diagnosis, staged intervention, and long-term follow-up. The integration of artificial intelligence (AI) and smart devices offers innovative approaches to address challenges in precision diagnosis and personalized treatment. This review synthesizes current applications of AI and smart devices across the MASLD care continuum, discusses their benefits and limitations, and outlines future directions to advance precision hepatology.
Introduction
MASLD, characterized by hepatic lipid accumulation linked to metabolic ...
New clinical trial demonstrates that eating beef each day does not affect risk factors for type 2 diabetes
2026-01-28
More than 135 million American adults are either living with or at risk for type 2 diabetes (T2D), elevating the need for more evidence-based dietary guidance to help this growing population achieve optimal health and reduce risks for T2D and its complications. Recently published findings from a randomized controlled trial (RCT) demonstrate that eating 6-7 ounces of beef per day does not impact risk factors for T2D, as well as other cardiometabolic health markers, in adults with prediabetes. The study, “Effects of Diets Containing Beef Compared with Poultry on Pancreatic β -Cell Function and Other Cardiometabolic Health Indicators in Males and ...
Powering AI from space, at scale
2026-01-28
Penn Engineers have developed a novel design for solar-powered data centers that will orbit the earth and could realistically scale to meet the growing demand for AI computing while reducing the environmental impact of data centers.
Reminiscent of a leafy plant, with multiple, hardware-containing stems connected to branching, leaf-like solar panels, the design leverages decades of research on “tethers,” rope-like cables that naturally orient themselves under the competing forces of gravity and centrifugal motion. This architecture could ...
New Watson College seed grants encourage interdisciplinary research
2026-01-28
To support research that could lead to significant external funding, Binghamton University’s Thomas J. Watson College of Engineering and Applied Science has established a new program offering seed grants to faculty members working in key topic areas.
The Watson College Seed Grant Program for Major Research Proposal Development is designed as a catalyst for accelerating interdisciplinary research, addressing pressing scientific and technological challenges while demonstrating a path to major research funding from external sponsors.
Six projects will receive $160,000 in ...
A new immune evasion pathway in cancer reveals statins as immunotherapy boosters
2026-01-28
Cancer immunotherapy has transformed modern oncology by harnessing body’s own immune system to combat malignant disease. Immune checkpoint inhibitors targeting the PD-1/PD-L1 pathway have produced durable responses in a subset of patients, raising hopes for long-term cancer control. However, for most patients, these therapies offer limited benefit, as tumors evolve mechanisms to evade immune surveillance. This limitation has shifted research focus toward the molecular basis of immune resistance, particularly strategies that suppress immune function beyond the local tumor microenvironment. ...
Understanding how smart polymer solutions transition to gels around body temperature
2026-01-28
In the world of modern medicine, most people focus on the active pharmaceutical ingredients, which are the chemicals that specifically fight a disease’s symptoms or causes. However, the unsung heroes of pharmacy are excipients—substances formulated alongside the active ingredients to ensure they reach the right part of the body at the right time. Simply put, excipients are as vital as the drugs themselves because they provide a controllable means of administration. A prominent example is thermoresponsive compounds that enable in situ gelling. These smart liquids, once administered to the body, transform into a solid gel in response to body heat, enabling the medication ...
Thermal transport modulation in YbN-alloyed ALN thin films to the glassy limit
2026-01-28
Discovering materials that exhibit completely insulating thermal behavior—or, conversely, extraordinarily high thermal conductivity—has long been a dream for researchers in materials physics. Traditionally, amorphous materials are known to possess very low thermal conductivity. This naturally leads to an important question: Can a crystalline material be engineered to achieve thermal conductivity close to that of an amorphous solid? Such a material would preserve the structural stability of a crystal while ...
Being a night owl may increase your heart risk
2026-01-28
Research Highlights:
Middle-aged and older adults — particularly women — who are naturally more active in the evenings may have worse cardiovascular health, as measured by the American Heart Association’s Life’s Essential 8 metric, in comparison to peers without a strong morning or evening preference.
Unhealthy behaviors among the night owls, such as poor diet quality, insufficient sleep and smoking, may account for their lower cardiovascular health profile, according to the analysis of data from the UK Biobank.
Helping ...